Effects of Qingda granule on patients with grade 1 hypertension at low-medium risk: study protocol for a randomized, controlled, double-blind clinical trial

Peer Review reports

Original Submission
3 Oct 2022	Submitted	Original manuscript
9 Oct 2022	Reviewed	Reviewer Report - Kirsty Loudon
24 Oct 2022	Reviewed	Reviewer Report - Zhiqing He
23 Nov 2022	Author responded	Author comments - Lin-zi Long
Resubmission - Version 2
23 Nov 2022	Submitted	Manuscript version 2
24 Nov 2022	Reviewed	Reviewer Report - Kirsty Loudon
3 Dec 2022	Reviewed	Reviewer Report - Zhiqing He
11 Dec 2022	Author responded	Author comments - Lin-zi Long
Resubmission - Version 3
11 Dec 2022	Submitted	Manuscript version 3
Publishing
12 Dec 2022	Editorially accepted
2 Jan 2023	Article published	10.1186/s13063-022-07006-0

Back to article page